IVan Howard - Apr 26, 2022 Form 3 Insider Report for Tenon Medical, Inc. (TNON)

Role: Director
Signature: /s/ Ivan Howard
Stock symbol: TNON
Transactions as of: Apr 26, 2022
Transactions value $: $0
Form type: 3
Date filed: 4/26/2022, 09:25 PM
Next filing: May 16, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TNON	COMMON STOCK						65.9K	Apr 26, 2022	See footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	TNON	Stock Options							Apr 26, 2022	Common Stock	13.7K	$0.62	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares are 25% of the Tenon Medical, Inc. common stock held by TCTIG, LLC for which Ivan Howard has a 25% equity interest therein and has control over how TCTIG, LLC will vote 25% of the common stock held by TCTIG, LLC
F2	Option shares held by TCTIG, LLC for which Ivan Howard has a 25% equity interest therein and has control over how TCTIG, LLC will vote 25% of the shares of common stock held by TCTIG, LLC. TCTIG, LLC was granted an option to purchase 109,353 shares (or 54,677 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $0.31 (or $0.62 post-split) per share with a grant date of June 19, 2014, which fully vested upon issuance.

Content

The shares are 25% of the Tenon Medical, Inc. common stock held by TCTIG, LLC for which Ivan Howard has a 25% equity interest therein and has control over how TCTIG, LLC will vote 25% of the common stock held by TCTIG, LLC

Option shares held by TCTIG, LLC for which Ivan Howard has a 25% equity interest therein and has control over how TCTIG, LLC will vote 25% of the shares of common stock held by TCTIG, LLC. TCTIG, LLC was granted an option to purchase 109,353 shares (or 54,677 shares after the 1-for-2 reverse stock split was effectuated on April 6, 2022) of common stock at an exercise price of $0.31 (or $0.62 post-split) per share with a grant date of June 19, 2014, which fully vested upon issuance.